Pacira Biosciences
PCRX
#5757
Rank
S$1.46 B
Marketcap
S$32.68
Share price
-1.67%
Change (1 day)
19.70%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: S$1.46 Billion

As of December 2025 Pacira Biosciences has a market cap of S$1.46 Billion. This makes Pacira Biosciences the world's 5757th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2025

End of year Market Cap

Year Marketcap Change
2025S$1.46 B19.07%
2024S$1.23 B-40.4%
2023S$2.06 B-12.87%
2022S$2.37 B-34.46%
2021S$3.62 B5.36%
2020S$3.43 B34.37%
2019S$2.55 B5.64%
2018S$2.42 B-2.19%
2017S$2.47 B41.67%
2016S$1.74 B-56.32%
2015S$4.00 B-5.49%
2014S$4.23 B72.86%
2013S$2.45 B251.53%
2012S$0.69 B261.12%
2011S$0.19 B

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of Pacira Biosciences was reported to be:

S$1.42 Billion
by Nasdaq info icon info icon
S$1.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Recro Pharma
REPH
S$0.15 B-89.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
S$0.59 B-59.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
S$10.47 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
S$0.32 B-77.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
S$0.95 B-34.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
S$1.93 B 31.96%๐Ÿ‡บ๐Ÿ‡ธ USA